5918 |
NEURO-ONCOLOGY |
Insulin-like growth factor-1 content and pattern of expression correlateswith histopathologic grade in diffusely infiltrating astrocytomas |
1999-04-01 |
10.1093/neuonc/1.2.109 |
Hirano Hirofumi, Lopes M. Beatriz S., Laws Edward R., Asakura Tetsuhiko, Goto Masamichi, Carpenter Joan E., Karns Larry R., VandenBerg Scott R. |
5917 |
NEURO-ONCOLOGY |
Cytogenetics and molecular genetics of childhood brain tumors |
1999-04-01 |
10.1093/neuonc/1.2.139 |
Biegel J. A. |
5916 |
NEURO-ONCOLOGY |
Roles of the functional loss of p53 and other genes inastrocytoma tumorigenesis and progression |
1999-04-01 |
10.1093/neuonc/1.2.124 |
Nozaki Michimasa, Tada Mitsuhiro, Kobayashi Hiroyuki, Zhang Chang-Liang, Sawamura Yutaka, Abe Hiroshi, Ishii Nobuaki, Van Meir Erwin G. |
5915 |
NEURO-ONCOLOGY |
The treatment of malignant brain tumors in infants and very youngchildren: An update of the Pediatric Oncology Group experience |
1999-04-01 |
10.1093/neuonc/1.2.152 |
Duffner Patricia K., Horowitz Marc E., Krischer Jeffrey P., Burger Peter C., Cohen Michael E., Sanford Robert A., Friedman Henry S., Kun Larry E. |
5914 |
NEURO-ONCOLOGY |
Characterization of paclitaxel (Taxol®) sensitivity in human glioma- and medulloblastoma-derived cell lines |
1999-04-01 |
10.1093/neuonc/1.2.101 |
Tseng Sheng Hong, Bobola Michael S., Berger Mitchel S., Silber John R. |
5913 |
NEURO-ONCOLOGY |
Society news |
1999-04-01 |
10.1215/15228517-1-2-162 |
Bogler O. |
5912 |
NEURO-ONCOLOGY |
Symposium Commentary |
1999-04-01 |
10.1093/neuonc/1.2.138 |
Friedman H. S., Kun L. E. |
5911 |
NEURO-ONCOLOGY |
Announcements |
1999-04-01 |
10.1215/15228517-1-2-163 |
|
5910 |
NEURO-ONCOLOGY |
Cytogenetics and molecular genetics of childhood brain tumors |
1999-04-01 |
10.1215/15228517-1-2-139 |
Biegel J. A. |
5909 |
NEURO-ONCOLOGY |
The blood-brain barrier in primary CNS lymphomas: Ultrastructuralevidence of endothelial cell death |
1999-04-01 |
10.1093/neuonc/1.2.89 |
Molnár Peter P., O'Neill Brian P., Scheithauer Bernd W., Groothuis Dennis R. |